Doug Hampton

Protalix BioTherapeutics Issues Letter to Stockholders

by

CARMIEL, Israel, May 30, 2023 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today announced the following letter from its President and Chief Executive Officer, Dror Bashan, to its stockholders and … Read more

JK Tech to showcase their latest Healthcare Technology Solutions at Healthcare Providers Transformation Assembly organized by The Millennium Alliance

by

NEW YORK, May 30, 2023 /PRNewswire/ — JK Tech, a global provider of next-generation Digital and Business Consulting Services has announced its participation in the upcoming Healthcare Providers Transformation Assembly organized by The Millennium Alliance. The assembly is scheduled in Chicago on June 20-21, 2023. Healthcare Providers Transformation Assembly will be an opportunity for healthcare … Read more

[Latest Report] Intraocular Lens Market is estimated to be US$ 7.9 billion by 2032 with a CAGR of 7.2% over the forecast period (2022-2032)

by

COVINA, Calif., May 30, 2023 /PRNewswire/ — According to Prophecy Market Insights “Intraocular Lens Market Flourishes with 7.2% CAGR, Envisaged to Cross US$ 7.9 billion Mark by 2032.” What is the Overview of Intraocular Lens Market? Intraocular Lenses (IOLs) are artificial, permanent lenses which can replace eye’s natural lens for restoring near & distant vision. Firstly, … Read more

PainTEQ Announces Decision from Patent Trial and Appeal Board in IPR Proceeding

by

TAMPA, Fla., May 30, 2023 /PRNewswire/ — PainTEQ, a fast-growing medical innovation company, announced that on May 24, 2023, the Patent Trial and Appeal Board (PTAB) issued a final written decision in an inter partes review (IPR) proceeding directed to U.S. Patent No. 10,426,539 (539 Patent), handing PainTEQ a decisive victory.  The patent is owned … Read more

a link with cardiovascular risk?

by

A short or long menstrual cycle is associated with a greater risk of heart disease, suggests a study. A study published in the journal Journal of the American Heart Association advance that the period duration has a role in the risk of cardiovascular disease. As a reminder, a menstrual cycle has an average duration of … Read more

The Foundation Assar Gabrielsson Prize recipients 2023 appointed

by

GOTHENBURG, Sweden, May 30, 2023 /PRNewswire/ — The Assar Gabrielsson Foundation has appointed Malin Lindén as the winner in the basic science research category and Aron Onerup as the winner in the clinical research category. The prize recipients are rewarded with SEK 100,000 each as extra research grants, administered by the Sahlgrenska Academy at the … Read more